Zhoukou Central Hospital
9
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
22%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Role: collaborator
AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
Role: collaborator
To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation
Role: collaborator
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
Role: collaborator
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
Role: collaborator
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
Role: collaborator
Management of Prostate Cancer in Central China
Role: collaborator
Radiotherapy vs Observation for CRPC
Role: collaborator
All 9 trials loaded